sarcopenia
Conditions
Interventions
control group:Shenqi Placebo Paste taken with warm water+routine western treatment and care
intervention group:Shenqi Paste taken with warm water+routine western treatment and care
Sponsors
Zhejiang Chinese Medical University
Eligibility
Sex/Gender
All
Age
60 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1) Confirmed diagnosis meets the western medical diagnostic criteria for type 2 diabetes mellitus; 2) Regularly taking treatment for =3 months; 3) Age is 60~85 years old; 4) Accompanied by myasthenia gravis according to the diagnosis; those who are willing to participate in the clinical trial; Those who meet the diagnosis of Chinese medicine identification and diagnosis belonging to spleen and kidney deficiency type. 5) Voluntarily participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1)The use of bioelectrical impedance is contraindicated for implantation of metallic devices or electronic medical instruments in the body such as installation of pacemakers 2)Pregnant or lactating women 3)Patients with serious abnormalities of body functions such as heart liver and hematopoietic system 4)Patients who are unable to cooperate with mental-emotional disorders (schizophrenia depression anxiety disorders etc.) 5) Combined malignant tumors serious infections severe gastrointestinal bleeding active tuberculosis and other diseases that affect nutritional status 6) Physical disability unwilling to participate in the study or unable to complete the follow-up 7) Patients with poor adherence to treatment 8) Patients who are participating in other clinical trials or taking traditional Chinese medicine.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skeletal muscle mass index;handgrip Strength;five-time chair stand test ; | — |
Secondary
| Measure | Time frame |
|---|---|
| FRAIL Scal;Mini-Nutritional Assessment Short Form ;Pittsburgh Sleep Quality Index Scale;International Physical Activity Questionnaire Short Form ;Diabetes Specific Quality of Life scale;Geriatric Depression Scale-15 ;traditional Chinese medicine syndrome score and efficacy criteria;Fasting blood glucose;glycosylated hemoglobin;homeostasis model assessment of insulin resistance ;CRP;TNF-a;IL-1ß;IL-6;IL-10;MSTN;Irisin;AGEs;Security monitoring indicators; | — |
Countries
China
Contacts
Public ContactQiuhua Sun
Zhejiang Chinese Medical University
Outcome results
None listed